We are live on ! Find out more
MC

Martin & Co Portfolio holdings

AUM $640M Turnover 2.94%
1-Year Est. Return 23.57%
This Fund
S&P 500
This Quarter Est. Return
+21.51%
1 Year Est. Return
+23.57%
3 Year Est. Return
+67.79%
5 Year Est. Return
+76.4%
10 Year Est. Return
+289.06%
AUM
$322M
AUM Growth
+$43M
Cap. Flow
-$10.7M
Cap. Flow %
-3.33%
Top 10 Hldgs %
28.59%
Holding
122
New
2
Increased
68
Reduced
45
Closed
5
Avg Time Held
5.2 years
Top 10 Avg Time Held
3.5 years
Top 20 Avg Time Held
2.9 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 41.1%
2 Technology 15.39%
3 Healthcare 9.35%
4 Financials 8.94%
5 Industrials 6.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MMSI icon
51
Merit Medical Systems
MMSI
$5.35B
$2.09M 0.65%
45,837
+409
+0.9% +$16.5K
2016 Q1
17 quarters
V icon
52
Visa
V
$750B
$2.02M 0.63%
10,457
-3,484
-25% -$636K
2018 Q1
9 quarters
ZIXI
53
DELISTED
Zix Corporation
ZIXI
$1.94M 0.6%
280,519
+6,257
+2% +$37.8K
2013 Q2
28 quarters
PBJ icon
54
Invesco Food & Beverage ETF
PBJ
$108M
$1.93M 0.6%
61,779
+1,395
+2% +$42.6K
2016 Q1
17 quarters
PB icon
55
Prosperity Bancshares
PB
$8.11B
$1.87M 0.58%
31,435
+1,332
+4% +$76.9K
2013 Q2
28 quarters
BCPC icon
56
Balchem Corp
BCPC
$5.44B
$1.85M 0.58%
19,543
+523
+3% +$48.9K
2013 Q2
28 quarters
ABT icon
57
Abbott
ABT
$181B
$1.85M 0.57%
20,185
+140
+0.7% +$12.7K
2013 Q2
28 quarters
MA icon
58
Mastercard
MA
$540B
$1.84M 0.57%
6,236
+55
+0.9% +$15.5K
2018 Q2
8 quarters
SKX icon
59
DELISTED
Skechers
SKX
$1.82M 0.56%
58,034
+2,561
+5% +$73.4K
2018 Q3
7 quarters
EWX icon
60
State Street SPDR S&P Emerging Markets Small Cap ETF
EWX
$654M
$1.79M 0.56%
43,967
+927
+2% +$34.7K
2013 Q2
28 quarters
HFWA icon
61
Heritage Financial
HFWA
$1.12B
$1.78M 0.55%
88,786
+1,795
+2% +$33.8K
2014 Q2
24 quarters
VZ icon
62
Verizon
VZ
$184B
$1.74M 0.54%
31,589
+265
+0.8% +$14.9K
2013 Q2
28 quarters
NXGN
63
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$1.73M 0.54%
157,294
+7,431
+5% +$77K
2013 Q2
28 quarters
TNC icon
64
Tennant Co
TNC
$1.13B
$1.73M 0.54%
26,533
+1,085
+4% +$66K
2013 Q2
28 quarters
FBNC icon
65
First Bancorp
FBNC
$2.5B
$1.7M 0.53%
67,705
+2,654
+4% +$63.9K
2013 Q2
28 quarters
JPM icon
66
JPMorgan Chase
JPM
$891B
$1.69M 0.53%
18,013
-125
-0.7% -$11.9K
2013 Q2
28 quarters
WMT icon
67
Walmart Inc
WMT
$935B
$1.66M 0.51%
41,457
-720
-2% -$29.6K
2013 Q2
28 quarters
DIS icon
68
Walt Disney
DIS
$191B
$1.59M 0.49%
14,265
+355
+3% +$39.2K
2013 Q2
28 quarters
PFE icon
69
Pfizer
PFE
$168B
$1.58M 0.49%
51,040
+1,409
+3% +$47.9K
2013 Q2
28 quarters
ABCB icon
70
Ameris Bancorp
ABCB
$5.35B
$1.57M 0.49%
66,552
+18,993
+40% +$446K
2019 Q3
3 quarters
PG icon
71
Procter & Gamble
PG
$365B
$1.56M 0.49%
13,088
-91
-0.7% -$10.6K
2013 Q2
28 quarters
CMCSA icon
72
Comcast
CMCSA
$77.3B
$1.56M 0.48%
39,983
-15
-0% -$571
2015 Q4
18 quarters
WLY icon
73
John Wiley & Sons Class A
WLY
$2.68B
$1.54M 0.48%
39,400
+1,867
+5% +$71.3K
2013 Q2
28 quarters
CSCO icon
74
Cisco
CSCO
$433B
$1.49M 0.46%
32,035
-110
-0.3% -$4.82K
2013 Q2
28 quarters
INTC icon
75
Intel
INTC
$504B
$1.48M 0.46%
24,717
+239
+1% +$14.3K
2013 Q2
28 quarters

Similar funds

Martin & Co's Q2 2020 Portfolio in Review

As of Q2 2020, Martin & Co held 122 positions worth $322M, up 15% from $279M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Martin & Co withdrew a net $10.7M in Q2 2020, closing 5 positions and reducing 45 holdings. Its most notable exit was Bio-Rad Laboratories Class A, an estimated $2.11M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, up from 40% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Martin & Co opened a new position in SouthState Bank Corp worth $1.46M.

  • Martin & Co's largest Q2 2020 buy was SouthState Bank Corp: 30,727 shares worth $1.46M.
  • Martin & Co added most to Ameris Bancorp in Q2 2020, an estimated $446K increase.
  • Martin & Co's biggest Q2 2020 reduction was Skyworks Solutions, cutting an estimated $1.38M.
  • Martin & Co fully exited Bio-Rad Laboratories Class A in Q2 2020, selling an estimated $2.11M.
  • Martin & Co's ten largest holdings make up 29% of its $322M portfolio in Q2 2020.
  • Martin & Co opened 2 new positions and closed 5 in Q2 2020.
  • Martin & Co's portfolio value rose 15% quarter-over-quarter to $322M.

Based on Martin & Co's 13F filing for Q2 2020, filed 14 Aug 2020.